
Passage Bio, Inc.
USD4.82
-0.04 (-0.72%)
CEO
William Chou
IPO Date
2020-02-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.90
Prev. Close
$4.85
Day Low
$4.76
Day High
$4.93
52W Low
$3.29
52W High
$20.00
Market Cap
$0.02B
Volume
0.02M
| 21 Apr 2026 |
| Chardan Capital |
| Buy |
| Neutral |
| downgrade |
| 4 Mar 2026 | Canaccord Genuity | Buy | Buy | maintain |
| 12 Nov 2025 | Chardan Capital | Buy | Buy | maintain |
| 14 Aug 2025 | Guggenheim | Buy | Buy | maintain |
| 14 Aug 2025 | Canaccord Genuity | Buy | Buy | maintain |
| 13 Aug 2025 | Wedbush | Outperform | Outperform | maintain |
| 24 Jun 2025 | Chardan Capital | Buy | Buy | maintain |